The Patent Finder

Asuragen, Inc.

Also on record
Records under this name other than the patents Asuragen, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 9 patents it holds.

Back to Asuragen, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 10,150,999Mirnas as Biomarkers for Distinguishing Benign from Malignant Thyroid Neoplasms
In force
 · High confidence
In forceHigh confidence
US 9,644,241Methods and Compositions Involving MIR-135B for Distinguishing Pancreatic Cancer from Benign Pancreatic Disease
In force
 · High confidence
In forceHigh confidence
US 8,003,320Methods and Compositions Involving Microrna
Lapsed on the fee record
Ended Aug 23, 2023 · High confidence
Lapsed on the fee recordEnded Aug 23, 2023High confidence
US 7,919,245Methods and Compositions Involving Microrna
Lapsed on the fee record
Ended Apr 5, 2023 · High confidence
Lapsed on the fee recordEnded Apr 5, 2023High confidence
US 7,888,010Methods and Compositions Involving Microrna
Lapsed on the fee record
Ended Feb 15, 2023 · High confidence
Lapsed on the fee recordEnded Feb 15, 2023High confidence
US 10,047,388Methods and Compositions Involving MicroRNA
Lapsed on the fee record
Ended Aug 14, 2022 · High confidence
Lapsed on the fee recordEnded Aug 14, 2022High confidence
US 8,735,074Mirna Biomarkers of Lung Disease
Lapsed on the fee record
Ended May 27, 2022 · High confidence
Lapsed on the fee recordEnded May 27, 2022High confidence
US 8,568,971Methods and Compositions Involving Microrna
Lapsed on the fee record
Ended Oct 29, 2021 · High confidence
Lapsed on the fee recordEnded Oct 29, 2021High confidence
US 8,465,914Method and Compositions Involving Microrna
Lapsed on the fee record
Ended Jun 18, 2021 · Medium confidence
Lapsed on the fee recordEnded Jun 18, 2021Medium confidence
US 8,361,714Micrornas Differentially Expressed in Cervical Cancer and Uses Thereof
Lapsed on the fee record
Ended Jan 29, 2021 · High confidence
Lapsed on the fee recordEnded Jan 29, 2021High confidence
10 of 74 records shown.
Pro members see all 74.
Pro members: see all 74 records
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited